EQUIL93 - A TOOL FOR EXPERIMENTAL AND CLINICAL UROLITHIASIS

An extensively updated version of the EQUIL software is described. The former version, designated EQUIL2, is widely used to study urolithias is and related areas of biomineralization. In this report, we discuss recent enhancements which give EQUIL93 an expanded scope of applicatio n. This program has been frequently used in studies of the physicochem ical processes underlying stone salt crystallization, especially cryst al growth and nucleation, but it has also been employed as an aid for in vivo research and as an evaluator of therapeutic measures. We illus trate several new applications, including some outside the urologic re alm, and we discuss how the enhanced software can be helpful in stone risk assessments